Key facts
- It has raised $3.2M; the latest was Seed Round ($3.2M) in Nov 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for EVT
- ·The full record, as it builds
Funding rounds
No funding rounds for EVT are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EVT
Provider of cardiovascular support services intended for surgical and critical care applications. The company offers adult and pediatric perfusion, autologous blood therapies, and platelet gel applications, enabling hospitals and physicians to maintain patient stability, perform perfusion-related procedures, and access support for complex cardiovascular cases.
- Sector
- Healthcare
- HQ
- San Antonio, TX, United States
- Founded
- 2001
- Employees
- 18
- Website
- evt-perfusion.com/
- Ownership
- Privately Held (backing)
EVT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EVT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EVT in its N-PORT filings yet. We sweep new filings monthly.